Authors
Latest:
Resource Use Among Nonvalvular Atrial Fibrillation PatientsThis study assesses comparative resource use for patients given a new diagnosis of nonvalvular atrial fibrillation treated with dabigatran or warfarin in a real-world setting.
Latest:
Specialty Pharmacy Makes Inroads in Urology PracticeIncreasing number of urology practices working with specialty pharmacies.
Latest:
mPharm: The Pharmacist as a Health Information Solution ProviderPharmacists can employ new tools to educate and engage patients while maximizing outcomes.
Latest:
Understanding and Managing Rosacea in Your PharmacyThis Continuing Education activity has been supported by an educational grant from Bayer HealthCare Pharmaceuticals Inc.
Latest:
Pregabalin Prior Authorization and Potential Medication-Medication and Medication-Condition InteractionsThis study of patients treated with pregabalin or duloxetine found that pregabalin prior authorization policies were associated with increased exposure to potential medication-medication and medication-condition interactions.
Latest:
Cost-Utility Analysis of Treatments for Advanced Non-Small Cell Lung CancerA national community-level study of Medicare patients with advanced non-small cell lung cancer found that adding targeted therapy to chemotherapy regimens was not cost-effective.
Latest:
It Is a "VRE" Serious ControversyWhat are the advantages and disadvantages of linezolid versus daptomycin for vancomycin-resistant enterococcus bacteremia?
Latest:
Potential Gender Differences of Exenatide in Outpatients With Type 2 Diabetes MellitusIn outpatients with type 2 diabetes mellitus, persistent exenatide treatment lowered glycated hemoglobin and hyperglycemia in both genders. Waist circumference and body weight were more reduced in women.
Latest:
Successful Collaborative Care Strategies for PharmacistsThe panel concludes its discussion with insights on successful strategies that can inform optimal collaborative care practices for cardiovascular risk reduction in patients with ASCVD.
Latest:
First Oral Tablet for Chemotherapy-induced Diarrhea in Dogs Receives Conditional FDA ApprovalThe prescription-only crofelemer delayed-release tablets were developed using a sustainable, plant-based formula.
Latest:
Cost-Effectiveness of Extended-Release Carbidopa-Levodopa for Advanced Parkinson's DiseaseExisting levodopa therapies for Parkinson’s disease often provide inadequate symptom control after prolonged treatment. This study assessed the cost-effectiveness of an extended-release carbidopa-levodopa formulation (IPX066).
Latest:
From Pharmacist to Entrepreneur: Pursuing a Career in Pharmacy OwnershipAs a pharmacy student, it is easy to see yourself working behind the counter at a major chain store when you think about your future.
Latest:
Using Patient-management Software for Improved CareThe pharmacist's role is changing from a technical function.
Latest:
Exploring Nursing Adherence Programs for Oral OncolyticsSpecialty pharmacies are becoming more involved in programs that focus on the management of oral oncolytics. The role of health care workers, including pharmacists, physicians, and nurses, is being defined as this therapeutic class grows.
Latest:
Devices, Not Just Doctors, Should Engage PatientsBut many products are designed for medical professionals, not consumers, and that needs to change.
Latest:
Year-Round Solutions Beyond the Influenza SeasonAs the margin between acquisition cost and sales price continues to narrow for traditional community pharmacy medication dispensing, many pharmacies are increasingly turning to service-based opportunities to improve their profitability.
Latest:
Legal Issues With Naloxone Availability Conferring Authority and Insulating From LiabilityThe rise of opioid overdoses nationally has expanded the role of pharmacists and advocacy for pharmacists to apply their knowledge and talents to emergency situations.
Latest:
Factors Associated With Employee Participation in a Value-Based Insurance Design InitiativeWe describe enrollment in a voluntary VBID initiative. Uptake was suboptimal, suggesting that barriers to enrollment may have significant implications for the overall effectiveness of VBID.
Latest:
Real-World Immunoglobulin Dose Adjustments and Impact on Utilization and CostsReal-world dose adjustments occurred in patients with primary immunodeficiency who switched from intravenous immunoglobulin to subcutaneous immunoglobulin 20%, with resulting implications for payers, patients, and plasma collection and supply.
Latest:
New Oral Anticoagulants for Stroke Prevention in Atrial FibrillationThis review summarizes the safety and efficacy of 3 new orally active anticoagulant drugs (dabigatran, rivaroxaban, apixaban) that can be used as alternatives to warfarin.
Latest:
Sunovion Pharmaceuticals' LatudaThe FDA approved Sunovion Pharmaceuticals' Latuda (lurasidone HCL), an atypical antipsychotic used to treat schizophrenia in adults 18 years and older.
Latest:
Economic Outcomes of Warfarin Discontinuation Among Patients with Atrial FibrillationThis study seeks to determine the economic effects of warfarin discontinuation in patients with nonvalvular atrial fibrillation.
Latest:
Evaluation of Therapeutic Interchange From Donepezil to Galantamine Extended-ReleaseTherapeutic interchange from donepezil to galantamine extended-release: a 3-month analysis.
